Kate W. Email

Senior Director Project Management . MoonLake Immunotherapeutics (NASDAQ MLTX)

Current Roles

Employees:
135
Revenue:
$25.6M
About
MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.
MoonLake Immunotherapeutics (NASDAQ MLTX) Address

Zug, null
CHE
MoonLake Immunotherapeutics (NASDAQ MLTX) Email